PARP3 and acute myeloid leukemia: To explore a deeper understanding of the significance of PARP3 in the clinical outcome of AML patients, we plotted the OS Kaplan–Meier curves for AML patients between the high- and low-PARP3 groups (cutoff: PARP3 median expression) using the TCGA-AML data.